Aspects of monoclonal antibody-mediated protection of mice against infection with virulent Semliki Forest virus.
W A
WA
Boere
C A
CA
Kraaijeveld
H
H
Snippe
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D000914:Antibodies, Viral / Q000276:immunology*; D000918:Antibody Specificity; D000920:Antibody-Dependent Cell Cytotoxicity; D000956:Antigens, Viral / Q000276:immunology; D004660:Encephalitis / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D000939:Epitopes / Q000032:analysis; D006023:Glycoproteins / Q000276:immunology; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009500:Neutralization Tests; D012672:Semliki forest virus / Q000276:immunology*; D014036:Togaviridae Infections / Q000276:immunology* / Q000517:prevention & control / Q000628:therapy; D010948:Viral Plaque Assay
D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral; D000956:Antigens, Viral; D000939:Epitopes; D006023:Glycoproteins